Abiraterone acetate (Zytiga) falls under anti androgens (anti-testosterone), which is used in order to treat prostate cancer.
Specifically it is recommended along with a corticosteroid for the metastatic castration resistant prostate cancer (mCRPC) and metastatic high risk castration sensitive prostate cancer (mCSPC).
In the month December, 2010, Centocor Ortho Biotech Inc. announced the NDA submission for abiraterone acetate 250 mg in order to treat patients with Metastatic Advanced Prostate Cancer.
In the month of April, 2011, theFood and Drug Administration approved abiraterone in order to treat Late-Stage Prostate Cancer.
In the month of December, 2012, the Food and Drug Administration expanded abiraterone’s use in order to treat the Late-Stage Prostate Cancer.
In the month of February, 2018, abiraterone acetate plus prednisone was approved in order to treat earlier forms of Metastatic Prostate Cancer.
The abiraterone 250 mg price is around 15,0000 INR for a supply of 120 tablets, depending on the wholesaler you visit. Any WHO-GDP & ISO certified pharmaceutical wholesaler company would be best to buy abiraterone.
